These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 19572407)

  • 1. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationships between exposure of periconceptional environmental risk factors and risks of common, structural birth defects].
    Chen G; Li C; Pei LJ; Zhang T; Zheng XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):212-5. PubMed ID: 18788515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of associations between birth defects and suspected human teratogens.
    Khoury MJ; James LM; Lynberg MC
    Am J Med Genet; 1991 Sep; 40(4):500-5. PubMed ID: 1746618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dysmorphology in birth defects epidemiology.
    Friedman JM
    Teratology; 1992 Feb; 45(2):187-93. PubMed ID: 1615428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of controls in case-control studies on maternal medication use and risk of birth defects.
    Bakker MK; de Walle HE; Dequito A; van den Berg PB; de Jong-van den Berg LT
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):652-6. PubMed ID: 17668455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens.
    Khoury MJ; James LM; Flanders WD; Erickson JD
    Teratology; 1992 Jul; 46(1):69-77. PubMed ID: 1641813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on new developments in the study of human teratogens.
    Shepard TH; Brent RL; Friedman JM; Jones KL; Miller RK; Moore CA; Polifka JE
    Teratology; 2002 Apr; 65(4):153-61. PubMed ID: 11948561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of adverse pregnancy outcomes and formaldehyde exposure in human and animal studies.
    Collins JJ; Ness R; Tyl RW; Krivanek N; Esmen NA; Hall TA
    Regul Toxicol Pharmacol; 2001 Aug; 34(1):17-34. PubMed ID: 11502153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.
    Czeizel AE
    Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of genotype-environment interaction in case-control studies of birth defects: how big a sample size?
    Khoury MJ; Beaty TH; Hwang SJ
    Teratology; 1995 May; 51(5):336-43. PubMed ID: 7482355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for teratogenic risks with the aid of malformation registries.
    Källén B
    Teratology; 1987 Feb; 35(1):47-52. PubMed ID: 3563936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the potential teratogenic effect of large doses of promethazine used for a suicide attempt by 32 pregnant women.
    Petik D; Acs N; Bánhidy F; Czeizel AE
    Toxicol Ind Health; 2008; 24(1-2):87-96. PubMed ID: 18818185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of evaluation of risks tied to drug exposure during pregnancy. Advantages and limits of epidemiology, interpretation of results].
    Robert-Gnansia E
    Therapie; 2002; 57(2):175-80. PubMed ID: 12185967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The possible teratogenic effect of levamisole treatment during pregnancy].
    Kazy Z; Puchó E; Czeizel E
    Orv Hetil; 2005 Dec; 146(49):2499-500. PubMed ID: 16398315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy.
    Brent RL
    Am J Obstet Gynecol; 2009 Jan; 200(1):4-24. PubMed ID: 19121655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paternal exposure and counselling: experience of a Teratology Information Service.
    De Santis M; Cesari E; Cavaliere A; Ligato MS; Nobili E; Visconti D; Caruso A
    Reprod Toxicol; 2008 Sep; 26(1):42-6. PubMed ID: 18598753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal risks of maternal pharmacotherapy: identifying signals.
    Koren G
    Handb Exp Pharmacol; 2011; 205():285-94. PubMed ID: 21882117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.